["Medication, Administered": "Fibrinolytic Therapy"]

Performance/Reporting Period

2019

Value Set Description from VSAC

Clinical Focus: This value set contains concepts that represent medications that are prescribed for fibrinolytic therapy in patients with an episode of acute myocardial infarction.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Administered. The intent of this data element is to identify patients who are prescribed fibrinolytic therapy during an episode of an acute myocardial infarction.
Inclusion Criteria: Includes only relevant concepts associated with generic and prescribable fibrinolytic agents. Only injectable dose forms should be included. Single ingredient.
Exclusion Criteria: No exclusions.

Constrained to codes in the Medication, Administered: Fibrinolytic Therapy value set (2.16.840.1.113883.3.666.5.736)

QDM Datatype and Definition (QDM Version 5.3)

"Medication, Administered"

Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient.

Timing: The Relevant Period addresses:

startTime - when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient),
stopTime - when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same)

NOTE – Measure developers should address multiple administrations over a period of time using CQL logic.

QDM Attributes

relevantPeriod

Relevant Period addresses the time between the start of an action to the end of an action. Each datatype using relevant period defines specific definitions for the start and stop time for the action listed.